FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2025/02/080528 [Registered on: 13/02/2025] Trial Registered Prospectively
Last Modified On: 07/02/2025
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Drug
Ayurveda 
Study Design  Other 
Public Title of Study   Evaluation of Synergistic activity of Honey as Anti-Hyperglycemic when given with Triphala Kashaya in Pre-Diabetes. 
Scientific Title of Study   EVALUATION OF YOGAVAHITVA OF MADHU WITH SPECIAL REFERENCE TO SAMYOGA ON ANTI- HYPERGLYCAEMIC ACTIVITY OF TRIPHALA IN PRE-DIABETES – A RANDOMIZED OPEN LABELLED CONTROLLED CLINICAL STUDY 
Trial Acronym  NIL 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  DR GRAMA SRIRANGARAJU SAHANA 
Designation  POST-GRADUATE SCHOLOR 
Affiliation  JSS AYURVEDA MEDICAL COLLEGE AND HOSPITAL, MYSURU, KARNATAKA 
Address  Department of Dravyaguna Vigyana , JSS Ayurveda Hospital, OPD: 7 JSS AYURVEDA MEDICAL COLLEGE AND HOSPITAL, MYSURU. #41/E, LALITHADRIPIURA ROAD, ALANAHALLI, MYSURU, KARNATAKA
Department of Dravyaguna Vigyana , JSS Ayurveda Hospital, OPD: 7
Mysore
KARNATAKA
570028
India 
Phone  9972901962  
Fax    
Email  gramasrisahana@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr Satish Pai 
Designation  Professor and HOD 
Affiliation  JSS AYURVEDA MEDICAL COLLEGE AND HOSPITAL, MYSURU, KARNATAKA 
Address  Department of Dravyaguna Vigyana , JSS Ayurveda Hospital, OPD: 7
Department of Dravyaguna Vigyana , JSS Ayurveda Hospital, OPD: 7 JSS AYURVEDA MEDICAL COLLEGE AND HOSPITAL, MYSURU. #41/E, LALITHADRIPIURA ROAD, ALANAHALLI, MYSURU, KARNATAKA
Mysore
KARNATAKA
570028
India 
Phone  8073822295  
Fax    
Email  satishayurveda@gmail.com  
 
Details of Contact Person
Public Query
 
Name  DR GRAMA SRIRANGARAJU SAHANA 
Designation  POST-GRADUATE SCHOLOR 
Affiliation  JSS AYURVEDA MEDICAL COLLEGE AND HOSPITAL, MYSURU, KARNATAKA 
Address  Department of Dravyaguna Vigyana , JSS Ayurveda Hospital, OPD: 7 JSS AYURVEDA MEDICAL COLLEGE AND HOSPITAL, MYSURU. #41/E, LALITHADRIPIURA ROAD, ALANAHALLI, MYSURU, KARNATAKA
Department of Dravyaguna Vigyana , JSS Ayurveda Hospital, OPD: 7
Mysore
KARNATAKA
570028
India 
Phone  9972901962  
Fax    
Email  gramasrisahana@gmail.com  
 
Source of Monetary or Material Support  
JSS Ayurveda Medical college and Hospital, #41/E LAlithadripura Road, Alanahalli, Mysuru -570028 Karnataka, India  
 
Primary Sponsor  
Name  DR GRAMA SRIRANGARAJU SAHANA 
Address  JSS AYURVEDA MEDICAL COLLEGE AND HOSPITAL, MYSURU. #41/E, LALITHADRIPIURA ROAD, ALANAHALLI, MYSURU, KARNATAKA Mysore, Karnataka 
Type of Sponsor  Other [Individual] 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
DR GRAMA SRIRANGARAJU SAHANA  JSS AYURVEDA MEDICAL COLLEGE AND HOSPITAL, MYSURU, KARNATAKA  Department of Dravyaguna Vigyana, OPD No: 7 #41/E, Lalithadripura Road Mysore -570028, Karnataka
Mysore
KARNATAKA 
9972901962

gramasrisahana@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Institutional Human Ethics Committee - JSS AYURVEDA MEDICAL COLLEGE AND HOSPITAL, MUSURU  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition:E119||Type 2 diabetes mellitus without complications. Ayurveda Condition: PRAMEHA-PURVARUPAM,  
 
Intervention / Comparator Agent  
snoIntervention/ComparatorTypeDrug-TypeProcedure NameDetails
1Comparator ArmLifestyle--Dinacarya: Diet and Exercise pattern, Ritucarya: Consumption of seasonal vegetables and fruits along with following the ritu anukula pathya and apathya will be decided on an individual subject basis., Acara Rasayana:, Other:Exercise - 3 to 4 times a week. Diet- 3 months duration, Pathya/Apathya:yes, Pathya:Ragi Peya, Upma, Mugdha Yusha, Wheat dosa, Mugdha khichdi, Ragi ball, Chapati with good quantity of vegetable serving, small portion of rice with Sambar or a Vegetable serving on a daily basis. Intake of Buttermilk, Ashgaurd juice, Ragi ambli., Apathya:Avoid Madhura,Katu and tikta Ahara
2Intervention ArmDrugClassical(1) Medicine Name: Triphala Kashaya , Reference: Kaiyadeva Nighantu, Route: Oral, Dosage Form: Kwatha/ Kashaya, Dose: 100(ml), Frequency: tds, Bhaishajya Kal: Adhobhakta, Duration: 90 Days, anupAna/sahapAna: Yes(details: -Sukoshna Jala), Additional Information: -100 ml per day in divided doses which consists of approximate 15.3g extract if given in a ghana vati dose in case of practical difficulty.
3Intervention ArmDrugClassical(1) Medicine Name: Madhu, Reference: Chakradatta Prameha Roga Adhikara, Route: Oral, Dosage Form: Kwatha/ Kashaya, Dose: 30(ml), Frequency: tds, Bhaishajya Kal: Adhobhakta, Duration: 90 Days, anupAna/sahapAna: Yes(details: -Triphala Kashaya), Additional Information: -
 
Inclusion Criteria  
Age From  25.00 Year(s)
Age To  60.00 Year(s)
Gender  Both 
Details  Patients diagnosed with Pre-Diabetes irrespective of gender and Socio-Economic status will be selected.
Subjects of age group 25-60 years will be selected
Fasting Blood Sugar level: 100-125mg/dl
Post Prandial Blood Sugar level: 140-199mg/dl
HbA1c: 5.7%-6.4%
Patients with pre-obese category and class 1 obesity
Patients fulfilling the Diagnostic criteria with or without associated complaints of
Polyuria, Polydipsia, Polyphagia, Tiredness and Weight parameter.  
 
ExclusionCriteria 
Details  Any other systemic disorder which requires emergency management.
Long term Diabetics with severe complications such as Diabetic neuropathy,
Diabetic Nephropathy, Retinopathy, Ischemic Heart Disease, Gestational Diabetes,
Diabetes Mellitus Type 1 and complaints related to mobility.
Secondary Diabetics, Bronze Diabetes and Stage 2 hypertensives.
Pregnant and Lactating Women.
Patients will Liver cirrhosis, Sexually Transmitted Disorders, HIV, Pancreatitis,
Hepatitis. 
 
Method of Generating Random Sequence   Coin toss, Lottery, toss of dice, shuffling cards etc 
Method of Concealment   An Open list of random numbers 
Blinding/Masking   Open Label 
Primary Outcome  
Outcome  TimePoints 
To Evaluate the Anti-Hyperglycaemic effect of Triphala in Pre-Diabetes.
To Evaluate the Yogavahitwa of Madhu with special reference to Samyoga on
Anti-Hyperglycaemic activity of Triphala in Pre-Diabetes.
To compare the Anti-Hyperglycaemic effect of Triphala and Madhu mishrita
Triphala with Standard Care [Diet and Exercise] 
6-12 weeks 
 
Secondary Outcome  
Outcome  TimePoints 
Fasting Blood Sugar level: 100-125mg/dl
Post Prandial Blood Sugar level: 140-199mg/dl
HbA1c: 5.7%-6.4%
Patients fulfilling the Diagnostic criteria with or without associated complaints of
Polyuria, Polydipsia, Polyphagia, Tiredness & Weight parameter 
6 to 12 Weeks 
 
Target Sample Size   Total Sample Size="60"
Sample Size from India="60" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   Phase 2/ Phase 3 
Date of First Enrollment (India)   01/03/2025 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="0"
Months="3"
Days="0" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary   Diabetes Mellitus is one of the largest global public health concerns, imposing a heavy global burden on public health as well as Socio-economic development. Diabetes Atlas 2021 reports that 10.5% of the adult population ranging from 20-29 years have Diabetes. By 2045, IDF projections show that 1 in 8 adults, will be living with Diabetes, an increase of 45%. In India, there are estimated 77 million people above the age of 18 years and nearly 25 million are prediabetics with more than 50% of people are unaware of their diabetic status. Hyperglycaemia-induced oxidative stress is central to the development of diabetes. Studies have shown that polyphenols could reduce and reverse oxidative stress associated hyperglycemia. Phenolics due to their poor bioavailability often fail in getting absorbed properly from gut and hence need bio-availability enhancers, which could bring enhanced effects. Honey has lower glycemic index and decreases the fasting blood glucose. Honey protects against metabolic syndrome by exerting antidiabetic activity. It keeps the gut healthy as it increases the bioavailability of Phenolics which are digested by the Gut microbe. The active principles of Triphala are predominantly hydrolysable tannins. Their antioxidant activity of Triphala correlates with their Antidiabetic property. Adults treated with Intensive Lifestyle Treatment have chances of achieving remission of diabetes. 
Close